04:07 PM EDT, 06/30/2025 (MT Newswires) -- Aaron G.L. Fletcher, 10% Owner, Director, on June 27, 2025, executed a purchase for 71,428 shares in Actuate Therapeutics ( ACTU ) for $499,996. Following the Form 4 filing with the SEC, Fletcher has control over a total of 10,196,456 shares of the company, with 10,196,456 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1652935/000110465925063991/xslF345X05/tm2519406-2_4seq1.xml